Howell, JessicaVan, HuyPham, MinhSawhney, RohitLi, FanBhat, PurnimaLubel, JohnKemp, WilliamBloom, StephenMajumdar, AvikMcCaughan, GeoffHall, SamuelSpelman, TimothyDoyle, Joseph S.Hellard, MargaretVisvanathan, KumarThompson, Alexander J.Drummer, Heidi E.Anderson, David2025-06-112025-06-11http://www.scopus.com/inward/record.url?scp=85139495577&partnerID=8YFLogxKhttps://hdl.handle.net/1885/733759039DA and HV hold a patent on the POC ALT1 test.JH has received investigator-initiated grant funding and speaker fees from Gilead Sciences and Eisai.The Burnet Institute was a shareholder in Nanjing BioPoint. JD’s and MH’s institution has received investigator-initiated funding for research from AbbVie and Gilead Sciences and consultancies for education from AbbVie.4en202210.1002/cld.126185139495577